We are live on ! Find out more
BHC icon

Bausch Health

452 hedge funds and large institutions have $36.9B invested in Bausch Health in 2014 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 140 increasing their positions, 188 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 30

25% more call options, than puts

Call options by funds: $721M | Put options by funds: $579M

14% more capital invested

Capital invested by funds: $32.4B → $36.9B (+$4.45B)

11% more funds holding

Funds holding: 409452 (+43)

0.95% more ownership

Funds ownership: 82.7%83.65% (+0.95%)

3% less funds holding in top 10

Funds holding in top 10: 6058 (-2)

26% less repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 188

Holders
452
Holders Change
+43
Holders Change %
+10.51%
% of All Funds
13.06%
Holding in Top 10
58
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-3.33%
% of All Funds
1.68%
New
77
Increased
140
Reduced
188
Closed
30
Calls
$721M
Puts
$579M
Net Calls
+$142M
Net Calls Change
-$47.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
76
Millennium Management
New York
$75.9M +$78.7M +575,504 New
Canada Pension Plan Investment Board
77
Canada Pension Plan Investment Board
Ontario, Canada
$75.1M +$33.3M +243,818 +75%
RCM
78
Ratan Capital Management
Florida
$74.1M +$12.1M +88,135 +19%
SCM
79
Sirios Capital Management
Massachusetts
$68.8M +$71.4M +521,945 New
VNIM
80
Vaughan Nelson Investment Management
Texas
$64.1M -$32.7M -239,292 -33%
BTS
81
BB&T Securities
Virginia
$62.9M -$114K -832 -2%
Allianz Asset Management
82
Allianz Asset Management
Germany
$61.1M +$6.99M +51,103 +12%
CS
83
Credit Suisse
Switzerland
$58.5M -$2.22M -16,232 -4%
Wells Fargo
84
Wells Fargo
California
$58.4M -$5.5M -40,189 -8%
TCIM
85
TIAA CREF Investment Management
New York
$51.6M +$14.3M +104,870 +37%
MAA
86
Managed Account Advisors
New Jersey
$49.6M -$14.1M -102,762 -21%
Bank of New York Mellon
87
Bank of New York Mellon
New York
$49M -$905K -6,621 -2%
RFC
88
Russell Frank Company
Washington
$48.8M -$39.3M -287,346 -44%
TI
89
Tyrian Investments
New York
$48.4M -$27.6M -201,906 -35%
BG
90
BlackRock Group
United Kingdom
$47.9M +$14M +102,384 +39%
MCMC
91
Matrix Capital Management Company
New Hampshire
$47M
Two Sigma Investments
92
Two Sigma Investments
New York
$44.6M +$45.3M +331,290 +4,974%
U
93
UBS
Switzerland
$42.7M -$7.52M -54,974 -14%
USAA
94
United Services Automobile Association
Texas
$40.1M +$1.66M +12,140 +4%
PCMF
95
Private Capital Management (Florida)
Florida
$40M -$9.07M -66,360 -18%
RG
96
Redmile Group
California
$39.2M +$40.6M +297,136 New
Northern Trust
97
Northern Trust
Illinois
$38.8M +$22M +160,542 +120%
Axa
98
Axa
France
$38.1M -$1.74M -12,720 -4%
OTPPB
99
Ontario Teachers' Pension Plan Board
Ontario, Canada
$37.1M -$24.8M -181,686 -39%
TCSAM
100
Tyrus Capital S.A.M.
Monaco
$36.9M +$38.3M +280,000 New

BHC Hedge Fund Activity: Q1 2014 in Review

452 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2014, worth a combined $36.9B — up 14% from $32.4B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new BHC positions and 30 closed out — a net gain of 47 holders — while 140 added to existing stakes and 188 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $412M. The largest seller was Fidelity Investments, cutting an estimated $443M.

  • 452 institutional investors held Bausch Health (BHC) as of Q1 2014, up from 409 in Q4 2013.
  • Funds reported $36.9B of Bausch Health stock for Q1 2014, up 14% quarter-over-quarter.
  • 77 funds opened new Bausch Health positions in Q1 2014 and 30 closed out, a net change of +47 holders.
  • The largest Bausch Health buyer in Q1 2014 was Bank of Montreal, an estimated $412M added.
  • The largest Bausch Health seller in Q1 2014 was Fidelity Investments, an estimated $443M sold.

Based on aggregated 13F filings for Q1 2014.